Clinical Trial Update: Treatment Continuation Study for Patients With ALS/MND Who Completed Study CMD-2019-001 [Phase 2]

View source ↗

Summary

Phase 2 treatment continuation study for ALS/MND patients who completed CMD-2019-001 has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Amyotrophic Lateral Sclerosis

Snippet

Sponsor: Collaborative Medicinal Development Pty Limited | Conditions: Amyotrophic Lateral Sclerosis | Phase 2 | Status: COMPLETED